Early Serum HBsAg Drop Is a Strong Predictor of HBeAg Seroconversion and HBsAg Loss to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients with Prior Nucleos(t)ide Analogue Exposure

BACKGROUND: High rates of HBeAg and/or HBsAg seroconversion or clearance have been achieved in chronic hepatitis B (CHB) patients receiving pegylated interferon (pegIFN) in addition to ongoing nucleos(t)ide analogue (NUC) treatment. In the present study, we aimed to evaluate HBsAg kinetics to predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qing, Zhang, Jun, Huang, Jianjun, Quan, Bin, Wu, Xiaoxin, Deng, Shengming, Han, Wenzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604672/
https://www.ncbi.nlm.nih.gov/pubmed/31230063
http://dx.doi.org/10.12659/MSM.916441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604672/
https://www.ncbi.nlm.nih.gov/pubmed/31230063
http://dx.doi.org/10.12659/MSM.916441

Ejemplares similares